Health
Targeted drug found effective in patients who have lung cancer with certain mutations – Medical Xpress
A targeted therapy called capmatinib can provide significant benefits to patients who have advanced lung cancer with specific gene mutations, according to recently published results from a phase two clinical trial. The trial, which is published in the New Eng…
A targeted therapy called capmatinib can provide significant benefits to patients who have advanced lung cancer with specific gene mutations, according to recently published results from a phase two clinical trial. The trial, which is published in the New England Journal of Medicine, was conducted by an international team led by investigators at Massachusetts General Hospital (MGH).
A protein called MET affects a wide range of processes within cells, and alterations that activate the MET gene, …
-
General22 hours agoDozens dead in Ukraine’s Sumy after Russian strike, acting mayor says
-
General23 hours agoDid my Coalition policy launch dream come true, and other thoughts
-
General12 hours agoUS eyes separate levy on exempted electronics: official
-
Noosa News9 hours agoWoman dies, 10 rushed to hospital after Bald Hills collision